For healthy individuals, HMPV causes mild illness and resolves on its own. However, the vulnerable population must take ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

China faces a surge in respiratory infections, likely linked to Human Metapneumovirus (HMPV), causing overcrowded hospitals.

The recent surge in Human Metapneumovirus (HMPV) cases in China has triggered global attention, prompting the Indian health ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives.

Researchers at the University of Pittsburgh have developed a new nasal swab test that identifies specific asthma subtypes in ...

Research using nasal swabs to identify asthma subtypes promises precise treatment. T2-high asthma may be less common than T2-low, suggesting a need for new treatments. Meanwhile, insights into why ...

Too little attention is paid to the connection between the two diseases. According to a recent survey commissioned by the Austrian Lung Union (ÖLU), ...

A new test can differentiate between various types of asthma via a nasal swab. Researchers hope it can eventually help match ...

The tool, developed by researchers at Pitt, could allow doctors to diagnose subtypes of the disease without putting patients ...

Northwest Asthma & Allergy Center (“NAAC”) filed a notice of data breach with the U.S. Department of Health and Human ...